Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

IMCR

Immunocore (IMCR)

Immunocore Holdings PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMCR
DateTimeSourceHeadlineSymbolCompany
11/03/202507:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMCRImmunocore Holdings PLC
11/03/202506:00GlobeNewswire Inc.Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025NASDAQ:IMCRImmunocore Holdings PLC
03/03/202523:00GlobeNewswire Inc.Immunocore to present at upcoming investor conferencesNASDAQ:IMCRImmunocore Holdings PLC
28/02/202508:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMCRImmunocore Holdings PLC
28/02/202508:29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMCRImmunocore Holdings PLC
26/02/202523:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMCRImmunocore Holdings PLC
26/02/202523:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:IMCRImmunocore Holdings PLC
26/02/202523:00GlobeNewswire Inc.Immunocore reports fourth quarter and full year 2024 financial results and provides a business updateNASDAQ:IMCRImmunocore Holdings PLC
20/02/202508:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMCRImmunocore Holdings PLC
20/02/202508:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMCRImmunocore Holdings PLC
20/02/202508:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMCRImmunocore Holdings PLC
20/02/202508:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMCRImmunocore Holdings PLC
19/02/202523:00GlobeNewswire Inc.Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025NASDAQ:IMCRImmunocore Holdings PLC
11/01/202508:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMCRImmunocore Holdings PLC
10/01/202523:00GlobeNewswire Inc.Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IMCRImmunocore Holdings PLC
06/01/202523:00GlobeNewswire Inc.Immunocore to present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IMCRImmunocore Holdings PLC
02/01/202523:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMCRImmunocore Holdings PLC
02/01/202523:00GlobeNewswire Inc.Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate DevelopmentNASDAQ:IMCRImmunocore Holdings PLC
23/12/202423:00GlobeNewswire Inc.Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAMENASDAQ:IMCRImmunocore Holdings PLC
17/12/202423:00GlobeNewswire Inc.Immunocore announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancersNASDAQ:IMCRImmunocore Holdings PLC
11/12/202423:00GlobeNewswire Inc.EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanomaNASDAQ:IMCRImmunocore Holdings PLC
03/12/202417:00GlobeNewswire Inc.Immunocore announces reimbursement agreement in England for KIMMTRAKâ–¼ for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanomaNASDAQ:IMCRImmunocore Holdings PLC
09/11/202408:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMCRImmunocore Holdings PLC
08/11/202423:00GlobeNewswire Inc.Immunocore to present at upcoming investor conferencesNASDAQ:IMCRImmunocore Holdings PLC
06/11/202423:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMCRImmunocore Holdings PLC
06/11/202423:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMCRImmunocore Holdings PLC
06/11/202423:00GlobeNewswire Inc.Immunocore reports third quarter financial results and provides a business updateNASDAQ:IMCRImmunocore Holdings PLC
16/09/202420:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMCRImmunocore Holdings PLC
14/09/202417:00GlobeNewswire Inc.Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancerNASDAQ:IMCRImmunocore Holdings PLC
13/09/202406:05GlobeNewswire Inc.Immunocore to present at the 2024 Cantor Global Healthcare ConferenceNASDAQ:IMCRImmunocore Holdings PLC
 Showing the most relevant articles for your search:NASDAQ:IMCR